Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes

Sponsor
University of Colorado, Denver (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT03840733
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
60
1
59.8
1

Study Details

Study Description

Brief Summary

This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss intervention. Outcomes of interest include change in body weight, body composition, physical activity, energy intake, and sleep. In addition, investigators will explore the associations between current physical activity, sleep, and energy intake patterns and body weight regulation.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    A total of 170 participants were initially enrolled in the comprehensive behavioral weight loss intervention.In this study, investigators will conduct a follow-up visit 3 years after the completion of the intervention. Only participants who completed the behavioral weight loss intervention will be enrolled in this study. Participants will undergo testing of body weight, body composition, physical activity patterns, energy intake patterns, sleep patterns, resting metabolic rate, and total daily energy expenditure.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes
    Actual Study Start Date :
    Jan 7, 2019
    Anticipated Primary Completion Date :
    Jan 1, 2024
    Anticipated Study Completion Date :
    Jan 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Participants from NCT01985568

    All subjects who previously enrolled in the Parent Study's behavioral weight loss intervention (NCT01985568).

    Outcome Measures

    Primary Outcome Measures

    1. Weight Change [Baseline to 54 months]

      Change in body weight (kg)

    2. Weight Maintenance [18 months to 54 months]

      Change in body weight (kg)

    3. Fat Mass Change [Baseline to 54 months]

      Change in Fat Mass (kg)

    4. Fat Free Mass Change [Baseline to 54 months]

      Change in Fat Free Mass (kg)

    5. Fat Mass Maintenance [18 months to 54 months]

      Change in Fat Mass (kg)

    6. Fat Free Mass Maintenance [18 months to 54 months]

      Change in Fat Free Mass (kg)

    Secondary Outcome Measures

    1. Change in Physical Activity Patterns [0, 6, 12, 18, 24, 54 month]

      Physical activity patterns as measured by SenseWear armband (min/day)

    2. Physical Activity Patterns [54 month]

      Physical activity patterns as measured by ActivPAL, Actigraph (min/day)

    3. Change in Sleep [0, 6, 12, 18, 24, 54 month]

      Sleep patterns as measured by SenseWear armband (h/day)

    4. Sleep Patterns [54 month]

      Sleep patterns as measured by Actiwatch-2, ActivPAL, Actigraph (h/day)

    5. Change in Energy Intake [0, 6, 12, 18, 54 month]

      Energy Intake patterns as measured by 3 day food record (kcal/day

    6. Energy Intake Patterns [54 month]

      Energy Intake patterns as measured by 24 hour food recall and meallogger smartphone application (kcal/day)

    7. Resting Metabolic Rate [54 month]

      Resting metabolic rate as measured using indirect calorimetry (kcal/day)

    8. Total Daily Energy Expenditure [54 month]

      Total Daily Energy Expenditure as measured by doubly labeled water (kcal/day)

    9. Physical Activity Energy Expenditure [54 month]

      Physical Activity Energy Expenditure as measured by doubly labeled water (kcal/day)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Previous enrollment in standard behavioral weight loss intervention (NCT01985568)

    • Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)

    • Capable and willing to give informed consent

    • Possess a smartphone to install and utilize the meal timing application

    • Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days

    • Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes

    Exclusion Criteria:
    • Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)

    • New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)

    • Women who became pregnant after completing the Parent Trial

    • Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Colorado Anschutz Medical Campus Aurora Colorado United States 80045

    Sponsors and Collaborators

    • University of Colorado, Denver
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Seth A Creasy, PhD, University of Colorado, Denver

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Colorado, Denver
    ClinicalTrials.gov Identifier:
    NCT03840733
    Other Study ID Numbers:
    • 18-1319
    • K01HL145023
    First Posted:
    Feb 15, 2019
    Last Update Posted:
    Apr 14, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Colorado, Denver
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 14, 2022